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Summary
Objective: To assess the relevance of using the aggregate physical component score (PCS) and mental component score (MCS) of the
Medical Outcomes Study 36-item Short Form Health Survey (SF-36) for patients with knee and hip osteoarthritis (OA).
Methods: We conducted a cross-sectional national survey in a primary care setting in France. A total of 1474 general practitioners enrolled
4183 patients with hip or knee OA. Construct validity of PCS and MCS was assessed by convergent and divergent validity and factor analysis.
Results: Records of 4133 patients (98.8%) were analyzed (2540 knee, 1593 hip OA). PCS mean scores were 32.0 8.4 and 31.8 8.4 and
MCS scores 47.1 11.0 and 46.8 11.1, for knee and hip OA, respectively. Acceptable convergent and divergent validity was observed, and
correlation between PCS and MCS mean scores was low (r¼ 0.14). However, factor analysis performed on the eight subscale scores failed to
support the use of PCS and MCS aggregate scores. It extracted two factors which were similar for both OA types and differed from the a priori
stratiﬁcation. Scores for two subscales usually attributed to MCS e emotional role and social functioning e were shared between factors, and
scores for another subscale e general health perception e usually belonging to the PCS was in the mental component factor.
Conclusions: Our results suggest that aggregate scores from the PCS and MCS of the SF-36 as they are currently deﬁned may not be optimal
for used in hip and knee OA patients to assess health-related quality of life.
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SocietyIntroduction
The patient point of view regarding health status has gained
importance in decision-making procedures and has been
considered a possible criterion standard to assess treat-
ment efﬁcacy1. Pain and physical disability, the two main
symptoms of knee and hip osteoarthritis (OA) have a signif-
icant impact on health-related quality of life (HRQoL)2.
Therefore, HRQoL has been widely accepted as one of
the key outcome measures in hip and knee OA3.
Several generic or speciﬁc instruments have been pro-
posed to assess HRQoL in chronic illnesses. The Medical
Outcomes Study (MOS) 36-item Short Form Health Survey
(SF-36) has become one of the most widely used generic
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2007.10instruments to assess quality of life4 and has been general-
ized progressively in the ﬁeld of rheumatology and orthope-
dics5,6. Although the HRQoL ﬁeld is continually expanding,
with some debate about the relative merits of the use of
generic or speciﬁc measures, most researchers recommend
using one generic HRQoL tool, such as the SF-36, and one
speciﬁc tool to assess outcomes in patients7e10. Disease-
speciﬁc instruments are thought to be more sensitive to
detect small but important clinical changes7, while generic
measures facilitate comparison between studies and can
capture the full, even unanticipated, effects of interventions7.
The SF-36 is composed of eight subscales that can be
summarized in two aggregate scores: the physical compo-
nent score (PCS), for physical functioning, physical role,
bodily pain, and general health perception, and the mental
component score (MCS), for mental health, vitality, emo-
tional role, and social functioning11. However, the relevance
of using the two aggregate scores representing the physical
and mental components in knee and hip OA remains uncer-
tain, because only one previous work, combining data from
several randomized trials of both OA and rheumatoid arthri-
tis, reported on their validity. Moreover, in this work, princi-
pal component analysis was not performed.13
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SF-36 PCS and MCS to assess HRQoL in knee and hip
OA. For this purpose we assessed the construct validity
of this questionnaire using convergent and divergent validity
and principal component analysis followed by orthogonal
rotation.
Methods
DESIGN
Data presented are from a cross-sectional survey of a
national sample of general practitioners (GPs) in France
assessing pain, disability and HRQoL of patients with hip
and knee OA in primary care.
RECRUITMENT OF GPs
In June 2004, 2300 GPs were selected at random from
a national database (MTV) according to a computerized
allocation with geographic stratiﬁcation and were invited to
participate in the survey.
RECRUITMENT OF PATIENTS
Between September 2004 and February 2005, each GP
was to enroll the ﬁrst three patients consulting for knee or
hip OA. Patients were included if (1) they were more than
45 years old (to avoid recruiting patients with peculiar forms
of early OA that might have different repercussions on
HRQoL), (2) the main motive for consulting was knee or
hip OA, and (3) they had radiographic evidence of hip or
knee OA. Patients were excluded if they (1) had both hip
and knee OA; (2) had had surgery of the knee or hip; (3)
had a disabling co-morbid disease that could interfere
with HRQoL (the main co-morbid conditions were stroke,
degenerative neurologic diseases, severe psychiatric disor-
ders, chronic inﬂammatory arthritis, heart failure, severe
respiratory disorders, systemic diseases, renal failure need-
ing dialysis); (4) were unable to understand, speak, or write
French; or (5) declined to participate.
ETHICAL APPROVAL
French bioethics legislation does not require consent
from the Hospital Ethics Committee for this type of survey.
The survey was conducted in compliance with the protocol
Good Clinical Practices and Declaration of Helsinki princi-
ples. In accordance with the French national law, GPs
and patients gave their written agreement to participate
after being informed of the survey protocol.
MAIN OUTCOME MEASURE
The French version of the SF-36 was used to assess
HRQoL4,12. This self-administered questionnaire covers
eight areas: physical function, physical role, bodily pain,
general health, vitality, social function, emotional role, and
mental health. For each area, the score ranges from 0 (worst
health status) to 100 (best health status). Scores of these
eight subscales can be summarized in two aggregate
scores11: the PCS, for physical functioning, physical role,
bodily pain, and general health perception and the MCS,
for mental health, vitality, emotional role, and social func-
tioning. We did not use norm-based scoring of SF-36
proﬁles because data on the general population arenot available in France and perceived HRQoL in the French
population may differ from populations for which data
are available (i.e., United States, Canada, Norway, and
Sweden).
PHYSICIAN QUESTIONNAIRE
The physician self-administered questionnaire concerned
demographics (age and sex) and professional data (years
and environment [rural/urban] of practice).
PATIENT QUESTIONNAIRE
GPs recorded the following data about patients: demo-
graphic data (age, sex), main motive for consultation (treat-
ment renewal, OA ﬂare-up, OA diagnosis), clinical data
(weight, height, body mass index, disease duration, OA
location [hip/knee], number of days with pain during the
previous month, number of days with disability during the
previous month), treatments for OA, and the Lequesne
index score of severity of OA13.
The patient self-administered questionnaire concerned
pain level (on an 11-point numeric scale, ranging from 0,
no pain; to 10, maximal pain), patients’ perceived disability
(on a 6-point Likert scale, from no disability to unbearable),
functional status (function subscale of the Western Ontario
and McMaster Universities Osteoarthritis Index [WOMAC]
for hip OA14,15 and modiﬁed WOMAC function subscale
score for knee OA16, 17, from 0, no disability; to 100, worst
disability), and HRQoL (SF-36). This questionnaire was
completed by the patient alone after the consultation at
the doctor’s clinic and supervised by the physician to avoid
missing data.
STATISTICAL ANALYSIS
Data analysis involved use of SAS 8.2 software (SAS
Institute Inc, Cary, NC, USA). Construct validity of the SF-36
PCS and MCS was investigated in four ways. Convergent
and divergent analysis was assessed by correlating the
questionnaire scores with scores on variables supposedly
assessing similar (convergent validity) or different (diver-
gent validity) dimensions or concepts. We assumed that
the SF-36 PCS would have convergent validity with the
WOMAC, Lequesne, patients’ perceived disability, and
pain level scores, the SF-36 MCS would have divergent val-
idity with these measures, and that both the SF-36 PCS and
MCS would have divergent validity with age, body mass in-
dex, and OA duration. Because a normal distribution could
not be demonstrated for all parameters studied, the non-
parametric Spearman rank coefﬁcient (r) was used to
assess the correlation between two quantitative variables.
Spearman’s coefﬁcients were interpreted as excellent (>0.91),
good (0.90e0.71), moderate (0.70e0.51), fair (0.50e0.31),
or little or none (<0.31)18. Internal consistencywas assessed
with the Cronbach’s a coefﬁcient. Principal component anal-
ysis was used to extract factors, from the eight subscale
scores of the SF-36. Then, independent factors were
obtained by use of the varimax rotation method.
Results
PHYSICIANS’ CHARACTERISTICS
A total of 1471 GPs (64% of GPs invited to participate)
enrolled at least one patient. Physicians’ mean age was
1015Osteoarthritis and Cartilage Vol. 15, No. 949 years old and most were male (85%), working in a rural
environment (59%). The mean number of patients included
by GPs was 2.81 0.52. Geographic distribution of GPs
followed that of the general population.
PATIENTS’ DEMOGRAPHIC AND CLINICAL DATA
Patients’ demographic characteristics and clinical data
according to OA location are shown in Table I. Scores of
the SF-36 subscales according to OA location are in Table II.
For comparison, scores of SF-36 subscales in the general
Swedish population are given (Sweden was chosen be-
cause it is the nearest European country where data from
the general population are available).
Most patients (57%) visited their GP for treatment renewal,
40% for OA ﬂare, and 3% for diagnosis of OA. According to
GPs, hand OA was present in 17% of the sample, spine OA
in 57%, and foot OA in 8%. Complaints induced by these
other OA locations were not recorded.
CONSTRUCT VALIDITY OF THE SF-36
Table III shows the results for convergent and divergent
validity of the PCS and MCS of the SF-36 for all patients
and for hip and knee OA groups. Similar and acceptable
convergent and divergent validity was observed, and corre-
lation between the two scores was low, as expected
(r¼ 0.14 for the whole population). PCS scores were fairly
correlated with disability (Lequesne score, WOMAC score,
and patient’s opinion) and pain level, whereas MCS scores
were poorly correlated with these outcome measures. The
score from one subscale of the SF-36, general health per-
ception, was correlated equally with PCS and MCS scores
(Table IV). Cronbach a coefﬁcients were 0.81, 0.80, and0.82 for all patients, and knee and hip OA groups, respec-
tively, for PCS, and 0.86, 0.85, and 0.87 for all patients,
and knee and hip OA groups, respectively, for PCS.
For all patients and for both OA groups, factor analysis of
the eight subscales (Table V) extracted two factors that
were similar and accounted for 70% (all patients), 69%
(knee OA), and 71% (hip OA) of the total variance. These
factors differed from the a priori stratiﬁcation (results most
often presented when using the SF-36, that is, the two fac-
tors PCS and MCS, PCS being the mean of physical func-
tioning, physical role, bodily pain, and general health
perception scores and MCS the mean of mental health,
vitality, emotional role, and social functioning scores). In fact,
two subscales supposedly belonging to MCS (emotional
role and social functioning) were shared between both fac-
tors and could not be clearly attributed to either, whereas
general health perception, supposedly belonging to PCS,
was clearly in the mental component factor. The loading
of each subscale score and items after varimax rotation
are shown in Table V.
Discussion
MAIN RESULTS
Our results suggest that aggregate scores from the
PCS and MCS of the SF-36 as they are currently deﬁned
may not be used in hip and knee OA to assess HRQoL.
The use of two aggregate scores, corresponding to phys-
ical components related to physical functioning, physical
role, and bodily pain, and mental components related to
mental health, general health perception, and vitality
could be an alternative. This must be conﬁrmed in further
studies.Table I
Demographic and clinical characteristics of patients with knee or hip OA
Whole sample, N¼ 4133 Knee OA, N¼ 2540 Hip OA, N¼ 1581
Age (meanSD), years 67 10 67 10 67 10
Age> 65 years (yes) 2510 (61%) 1539 (61%) 971 (61%)
Sex (M) 1703 (42%) 994 (40%) 709 (45%)
OA duration (meanSD), years 5.7 4.9 5.9 5.0 5.4 4.8
Body mass index (kg/m2) 27.7 4.6 28.2 4.8 27.0 4.0
Main reason for consulting GPs
Treatment renewal 2362 (57%) 1430 (56%) 932 (59%)
OA ﬂare-up 1650 (40%) 1034 (41%) 616 (38%)
OA diagnosis 121 (3%) 68 (3%) 43 (3%)
Medications
Analgesics (yes) 3317 (84%) 2014 (84%) 1303 (85%)
NSAIDs (yes) 3120 (79%) 1876 (78%) 1244 (81%)
SYSADOA (yes) 1725 (44%) 1086 (45%) 639 (42%)
Pain level (meanSD) 5.2 2.0 5.2 2.1 5.3 2.3
Number of days with pain during the last month (meanSD) 17.4 9.1 17.2 8.9 17.7 9.2
Number of days with disability during the last month (meanSD) 18.2 9.3 18.1 9.2 18.5 9.4
Self-rated disability
None 31 (1%) 18 (1%) 13 (1%)
Weak 469 (12%) 266 (11%) 203 (13%)
Moderate 1567 (39%) 957 (39%) 610 (39%)
Severe 1365 (34%) 869 (35%) 496 (32%)
Extremely severe 556 (14%) 347 (14%) 209 (14%)
Unbearable 49 (1%) 28 (1%) 21 (1%)
Lequesne index score (0e24) 11.9 4.3 12.0 4.2 11.8 4.3
WOMAC score (0e100) 45.6 18.8 45.7 19.3 45.2 17.3
Values are number of patients (percentages), unless indicated; NSAIDs¼ nonsteroidal anti-inﬂammatory drugs; SYSADOA¼ slow-acting
drug for OA.
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MeanSD health-related quality of life scores assessed by the SF-36 subscales in knee and hip OA
Whole sample,
N¼ 4133
Knee OA,
N¼ 2540
Hip OA,
N¼ 1581
Swedish general
population,
N¼ 8930*
Physical functioning 39.6 24.5 40.0 24.5 39.0 24.6 87.9 19.6
Physical role 31.8 37.1 32.9 37.5 30.1 36.5 83.2 31.8
Bodily pain 39.6 15.7 39.6 15.6 39.7 15.8 74.8 26.1
General health perception 48.7 18.4 48.7 18.3 48.6 18.6 75.8 22.2
Mental health 60.9 18.8 61.1 18.8 60.6 18.9 80.9 18.9
Emotional role 55.2 43.0 55.8 43.1 54.3 42.9 85.7 29.2
Vitality 51.4 18.2 51.7 18.2 51.4 18.2 68.8 22.8
Social functioning 60.5 23.0 61.2 22.7 59.4 23.6 88.6 20.3
PCS 31.9 8.4 32.0 8.4 31.8 8.4
MCS 47.0 11.0 47.1 10.9 46.8 11.1
*Data available at http://www.sf-36.org/nbscalc/index.shtml.Although the PCS and MCS have acceptable convergent
and divergent validity for both locations of OA, their factorial
structure was not totally conﬁrmed in this study. Less than
optimal (Cronbach’s a coefﬁcients values< 0.90) but
acceptable (Cronbach’s a coefﬁcients values> 0.70) inter-
nal consistency was observed> 0.70)19. Factor analysis
extracted two factors that were distinct from the a priori strat-
iﬁcation, and scores of two subscales supposedly belonging
to the mental component (emotional role and social function-
ing) had dual-factor content and one supposedly belonging
to the physical component (general health perception) was
clearly in the mental component factor. The two subscales
with dual-factor content also had only moderate (less than
0.7) loading in each factor, and both scores could probably
be presented independently.
The factorial complexity of the SF-36 has already been
pointed out by the analysis of three British surveys of adults
living at home to obtain population norms for the SF-36 in
the United Kingdom20. General health perception and vital-
ity scores correlated equally with PCS and MCS in previous
studies of French and North American populations12, 21 and
had a dual-factor content in a sample of patients with OA
and rheumatoid arthritis5. Our results correlating each
SF-36 subscale score with PCS and MCS scores conﬁrmed
those reported by Kosinski et al.5, except that general
health perception and vitality had a higher correlation with
the MCS score in our sample than in Kosinki’s study
(r¼ 0.57 vs 0.47, and r¼ 0.74 vs 0.60, for general health
perception and vitality, respectively). These small differ-
ences may be due to different cultural backgrounds or dif-
ferences in patients recruited (strictly hip or knee OApatients in primary care in our study, and OA or rheumatoid
arthritis patients recruited for randomized clinical trials in
Kosinsky’s study). Finally, in systemic sclerosis, factor anal-
ysis extracted three factors, the physical factor restricted to
physical functioning and the mental factor to mental health
and vitality22.
Therefore, the relevanceof useof theSF-36PCSandMCS
as they are currently deﬁned, at least for study of HRQoL in
knee and hip OA, is debatable. Obviously, the main advan-
tage in summarizing HRQoL by two predeﬁned aggregate
scores is homogeneity of assessment and the ability to com-
pare different clinical situations and settings. However, stud-
ies reporting different factorial structures of the SF-36 in
different situations5,12,20e22 raise the question of whether dis-
ease-speciﬁc SF-36 aggregate scores should be used and
imply the risk of presenting scores that possibly mix apples
with oranges if deciding to do so. The use of disease-speciﬁc
aggregate scores does not defeat the purpose of a generic in-
strument. The eight SF-36 subscales are very useful to com-
pare the HRQoL between clinical situations and between
patients and the general population. The question is more
about using generic summary scores because we are not
sure what we are measuring and whether we are measuring
the same things in different clinical situations. Therefore, use
of generic summary scores to compare clinical situations
should be interpreted with extreme caution.
We did not observe signiﬁcant differences in SF-36 sub-
scale scores between knee and hip OA patients, and princi-
pal component analysis followed by orthogonal rotation
extracted similar factors for both locations of the disease.
These results suggest that patients consulting their GPsTable III
Convergent and divergent validity of the PCS and MCS of the SF-36 in knee and hip OA (Spearman’s rank correlation coefficient)
Whole sample,
N¼ 4133
Knee OA,
N¼ 2540
Hip OA,
N¼ 1581
PCS MCS PCS MCS PCS MCS
Lequesne index score 0.64 0.30 0.64 0.25 0.64 0.38
WOMAC score 0.65 0.39 0.62 0.37 0.68 0.42
Patient’s opinion of disability 0.52 0.34 0.51 0.32 0.53 0.37
Pain level 0.58 0.36 0.57 0.33 0.59 0.42
Age 0.20 0.01 0.21 0.02 0.19 0.01
OA duration 0.22 0.02 0.22 0.02 0.22 0.03
Body mass index 0.14 0.04 0.15 0.04 0.11 0.04
PCS 1.00 0.14 1.00 0.12 1.00 0.16
MCS 0.14 1.00 0.12 1.00 0.16 1.00
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Correlation of the PCS and MCS of the SF-36 with its subscale scores in knee and hip OA (Spearman’s rank correlation coefficient)
Whole sample,
N¼ 4133
Knee OA,
N¼ 2540
Hip OA,
N¼ 1581
PCS MCS PCS MCS PCS MCS
Physical functioning 0.84 0.30 0.84 0.27 0.85 0.32
Physical role 0.70 0.42 0.71 0.41 0.69 0.43
Bodily pain 0.72 0.43 0.71 0.41 0.73 0.45
General health perception 0.58 0.57 0.58 0.56 0.58 0.58
Mental health 0.26 0.87 0.25 0.86 0.27 0.89
Emotional role 0.22 0.83 0.21 0.83 0.24 0.83
Social functioning 0.55 0.70 0.54 0.70 0.57 0.71
Vitality 0.47 0.74 0.46 0.73 0.48 0.76for knee and hip OA have a similar level and type of HRQoL
change and that similar aggregate scores could be used for
patients with both types of the disease.
LIMITATIONS
We used exploratory and not conﬁrmatory analysis to
assess the factor structure of the eight subscales of the
SF-36. Conﬁrmatory analysis is considered more appropriate
if the aim of a study is to conﬁrm the existing second-order
two-factor structure of the eight subscales of the SF-3623.
However, exploratory analysis is considered appropriate if
the aim of the study is to examine the factor structure of
the SF-36 in a population or language in which the SF-36
has not yet been evaluated23. Because the factorial struc-
ture of the SF-36 in hip and knee OA with use of principal
component analysis followed by rotation is unknown and
only preliminary psychometric evaluation of the SF-36 in
the French population has been published12, we considered
that exploratory analysis was relevant.
Although we tried to ensure a national representation of
GPs, our sample differed slightly from the general popula-
tion of French GPs (national register) by involving more
men (85.0% vs 71.3% in the national register) who were
older (49 years vs 47 years in the national register) and
more likely worked in a rural environment (no reliable dataavailable because of different deﬁnitions of rural/urban).
This result has already been observed in previous national
surveys of acute and subacute low back pain conducted in
a primary and secondary care setting24,25. One explanation
could be that older men working in a rural environment are
more likely to participate in this type of survey. The re-
sponse rate achieved was low but higher than that previ-
ously reported for this kind of survey in this setting in
France24. Therefore, we cannot exclude the fact that our
patient sample differs slightly from the knee and hip OA
population consulting GPs in France. These limitations
might bias the generalizability of our results. However, to
our knowledge, the factorial structure of an HRQoL instru-
ment has never been tested before in such a large sample
of patients with OA.
Another possible limitation is that we used a deﬁnition of
OA based on GPs opinion and X-rays with probably a poor
interrater reliability of X-rays among GPs. Finally, even
though hip or knee OA had to be the main complaint to
be recruited for the survey, hand OA was present in 17%
of the sample, spine OA in 57%, and foot OA in 8%, and
we did not record complaints induced by these other OA
locations that could have interfered with HRQoL.
In conclusion, the relevance of using the SF-36 PCS and
MCS to assess HRQoL in knee and hip OA is debatable.
Our results suggest that hip and knee OA-speciﬁc aggregateTable V
Factor analysis and Varimax rotated factor matrix of the SF-36 with its eight subscales
SF-36 with the eight subscales of the questionnaire
Factor Eigenvalue % Variance Cumulative %
Whole
sample
Knee
OA
Hip
OA
Whole
sample
Knee
OA
Hip
OA
Whole
sample
Knee
OA
Hip
OA
Factor 1 4.77 4.70 4.87 0.60 0.59 0.61 0.60 0.59 0.61
Factor 2 0.85 0.85 0.85 0.11 0.11 0.11 0.71 0.70 0.72
SF-36: The highest loaded subscale score is italicized, except for subscale scores that are equally correlated in both factors
Subscales Factor 1 Factor 2
Whole
sample
Knee
OA
Hip
OA
Whole
sample
Knee
OA
Hip
OA
Physical functioning 0.30 0.30 0.30 0.75 0.74 0.76
Physical role 0.21 0.21 0.21 0.82 0.82 0.81
Bodily pain 0.33 0.33 0.35 0.77 0.76 0.79
General health perception 0.74 0.74 0.75 0.34 0.34 0.34
Mental health 0.90 0.90 0.90 0.19 0.18 0.20
Emotional role 0.55 0.54 0.57 0.43 0.43 0.44
Social functioning 0.63 0.62 0.64 0.57 0.57 0.58
Vitality 0.84 0.84 0.85 0.32 0.32 0.32
1018 F. Rannou et al.: SF-36 aggregate scores in hip and knee OAscores of the MOS SF-36 might reﬂect more accurately the
HRQoL of patients. This has to be conﬁrmed in further studies.
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